Portcullis Lane, Ludlow, SY8 1GT Send us an online question or request
Telephone: 01584 872 939
We are closed. Call 111 for urgent advice out of hours.
Reminder to Patients: Open forum meeting this Saturday 7th September from 10am-12am. Good luck Dr Jenny Hartley in the Dragon’s Back Race Good luck to all students waiting for their A level results tomorrow Save the Dates RSV, Covid and Flu vaccine clinics 2024 National Collective Action by GPs Zero Tolerance Policy Update on Computer systems Good News! 21/7/2024. Update on Computer systems 20/7/2024. Computer failure 19/7/2024 GPs Are On Your Side
The NHS is offering new antibody and antiviral treatments to people with coronavirus (COVID-19) who are at highest risk of becoming seriously ill.
2 types of COVID-19 treatment are available:
These treatments can help some people manage their COVID-19 symptoms and reduce the risk of becoming seriously ill.
MOLNUPIRAVIR
Molnupiravir is an antiviral ORAL medicine.
SOTROVIMAB
Sotrovimab is a biological medicine. It is also known as a neutralising monoclonal antibody (nMAb). It is only available to patients who are at the highest risk from Covid-19 or SHIELDED.
A list of those considered to be at the highest risk is given below.
Where an nMAB is contraindicated, not recommended or the administration of a nMAB is not possible, patients may be treated with a five-day course of molnupiravir, provided the onset of symptoms is in the last 5 days.
It is given intravenously, within 5 days of symptom onset.
One trial found a single dose of sotrovimab reduced the risk of hospitalisation and death by 85% when given to high risk unvaccinated hospitalised patients with Covid 19.
https://www.nejm.org/doi/full/10.1056/NEJMoa2107934